Access to Opioid Reversal Meds
Access to opioid reversal medications like naloxone and nalmefene remains limited due to regulatory barriers, stigma, and uneven policy implementation. This restricted access leads to preventable overdose deaths and missed opportunities for treatment. While some government efforts have improved naloxone availability, newer medications remain underutilized. Stigma—both systemic and individual—continues to hinder access and acceptance. To … Read more